Share on StockTwits

Bodycote PLC (LON:BOY)‘s stock had its “buy” rating restated by investment analysts at Jefferies Group in a note issued to investors on Friday. They currently have a GBX 825 ($14.01) price target on the stock. Jefferies Group’s price objective would indicate a potential upside of 20.00% from the company’s current price.

Shares of Bodycote PLC (LON:BOY) traded down 0.94% during mid-day trading on Friday, hitting GBX 687.50. 193,564 shares of the company’s stock traded hands. Bodycote PLC has a one year low of GBX 595.00 and a one year high of GBX 832.00. The stock has a 50-day moving average of GBX 693.1 and a 200-day moving average of GBX 726.1. The company’s market cap is £1.308 billion.

The company also recently announced a dividend, which is scheduled for Friday, November 7th. Shareholders of record on Wednesday, October 1st will be paid a dividend of GBX 4.60 ($0.08) per share. This represents a dividend yield of 0.66%. The ex-dividend date is Wednesday, October 1st.

A number of other analysts have also recently weighed in on BOY. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Bodycote PLC in a research note on Thursday. They now have a GBX 810 ($13.75) price target on the stock. Separately, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Bodycote PLC in a research note on Thursday. They now have a GBX 825 ($14.01) price target on the stock. Finally, analysts at Investec raised their price target on shares of Bodycote PLC from GBX 760 ($12.91) to GBX 775 ($13.16) in a research note on Thursday. They now have a “buy” rating on the stock. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the stock. Bodycote PLC has an average rating of “Hold” and a consensus price target of GBX 889.17 ($15.10).

Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.